Therefore, in this study we tried to determine the role of impaired IS, together with the relevant changes in insulin and PAI-1 levels in T2D patients as well as nondiabetics with ischemic stroke. The gene discussed is SERPINE1; the disease is type 2 diabetes mellitus.